Syngene International Intrinsic Value
SYNGENE Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹189.87 | ₹151.90 - ₹227.84 | -70.0% | EPS: ₹6.68, Sector P/E: 22x |
| Book Value Method | asset | ₹234.59 | ₹211.13 - ₹258.05 | -62.9% | Book Value/Share: ₹117.30, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹189.87 | ₹170.88 - ₹208.86 | -70.0% | Revenue/Share: ₹91.91, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹253.16 | ₹227.84 - ₹278.48 | -60.0% | EBITDA: ₹860.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹373.89 | ₹299.11 - ₹448.67 | -40.9% | CF Growth: 13.6%, Discount: 15% |
| PEG Ratio Method | growth | ₹189.87 | ₹170.88 - ₹208.86 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹189.87 | ₹170.88 - ₹208.86 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹316.45 | ₹284.81 - ₹348.10 | -50.0% | ROE: 5.7%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹189.87 | ₹170.88 - ₹208.86 | -70.0% | EPS: ₹6.68, BVPS: ₹117.30 |
Want to compare with current market value? Check SYNGENE share price latest .
Valuation Comparison Chart
SYNGENE Intrinsic Value Analysis
What is the intrinsic value of SYNGENE?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Syngene International (SYNGENE) is ₹189.87 (median value). With the current market price of ₹632.90, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹189.87 to ₹373.89, indicating ₹189.87 - ₹373.89.
Is SYNGENE undervalued or overvalued?
Based on our multi-method analysis, Syngene International (SYNGENE) appears to be trading above calculated value by approximately 70.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 3.40 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.44 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 5.7% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 22.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.55x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Syngene International
Additional stock information and data for SYNGENE
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹1,168 Cr | ₹796 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹1,042 Cr | ₹795 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹824 Cr | ₹498 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹581 Cr | ₹276 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹701 Cr | ₹387 Cr | Positive Free Cash Flow | 8/10 |